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Proliferation of aneuploid human cells is limited by
a p53-dependent mechanism
Sarah L. Thompson1,2 and Duane A. Compton1,2
1

Department of Biochemistry and 2Norris Cotton Cancer Center, Dartmouth Medical School, Hanover, NH 03755

THE JOURNAL OF CELL BIOLOGY

M

ost solid tumors are aneuploid, and it has been
proposed that aneuploidy is the consequence
of an elevated rate of chromosome missegregation in a process called chromosomal instability (CIN).
However, the relationship of aneuploidy and CIN is unclear because the proliferation of cultured diploid cells
is compromised by chromosome missegregation. The
mechanism for this intolerance of nondiploid genomes is
unknown. In this study, we show that in otherwise diploid
human cells, chromosome missegregation causes a cell
cycle delay with nuclear accumulation of the tumor suppressor p53 and the cyclin kinase inhibitor p21. Deletion

of the p53 gene permits the accumulation of nondiploid
cells such that CIN generates cells with aneuploid genomes that resemble many human tumors. Thus, the p53
pathway plays an important role in limiting the propagation of aneuploid human cells in culture to preserve the
diploid karyotype of the population. These data fit with
the concordance of aneuploidy and disruption of the p53
pathway in many tumors, but the presence of aneuploid
cells in some normal human and mouse tissues indicates
that there are known exceptions to the involvement of p53
in aneuploid cells and that tissue context may be important in how cells respond to aneuploidy.

Introduction
Aneuploidy is defined as an abnormal number of chromosomes
and is one of the most prominent features in solid tumors.
Karyotypes of tumors frequently range from 40 to 60 chromosomes (http://cgap.nci.nih.gov/Chromosomes/Mitelman), and it
has been proposed that this level of aneuploidy is generated
through an elevated rate of single chromosome missegregation
as seen in chromosomal instability (CIN; Lengauer et al., 1998).
However, the relationship between CIN and aneuploidy is unclear as we recently showed that aneuploid human cells do not
propagate efficiently when chromosome missegregation rates
are elevated to levels that are equivalent to tumor cells with CIN
(Thompson and Compton, 2008). Moreover, mice heterozygous
for mutations in genes encoding the checkpoint proteins Mad1
and -2 and CENP-E have elevated chromosome missegregation
rates but only form tumors late in life in selective tissues
(Michel et al., 2001; Iwanaga et al., 2007; Weaver et al., 2007).
Some groups argue that this delay in tumor formation is caused
by a requirement for other cooperating mutations (Holland and
Cleveland, 2009). Another possibility is that only specific chromosome combinations promote tumorigenesis. Not all chromoCorrespondence to Duane A. Compton: duane.a.compton@dartmouth.edu
Abbreviations used in this paper: CIN, chromosomal instability; MCAK, mitotic
centromere–associated kinesin; NEB, nuclear envelope breakdown.
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somes may have the same impact on cell viability, but data from
others showing reduced growth rates in aneuploid strains of
budding yeast (Torres et al., 2007) and mouse cell lines
(Williams et al., 2008) led those investigators to suggest that
growth retardation in response to aneuploidy is a general phenomenon (Torres et al., 2008). However, aneuploid cell lines
isolated from tumors grow efficiently in culture, indicating that
they have overcome this limitation. From these data, we hypoth
esized that aneuploid tumor cells only arise from otherwise diploid somatic cells when chromosome missegregation is coupled
to the acquisition of tolerance for a nondiploid genome (Thompson
and Compton, 2008). However, the mechanism underlying the
intolerance for a nondiploid genome is unknown.

Results
To follow the fate of live cells that missegregate chromosomes,
we generated HCT116 cells that expressed LacIGFP and had
multiple copies of lacO integrated into a single chromosomal
locus (Robinett et al., 1996; Straight et al., 1996). We chose to
© 2010 Thompson and Compton This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jcb.org/misc/terms.shtml). After six months it is available under a
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,
as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
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Figure 1. HCT116 cells with a single marked chromosome. Interphase (top left) and anaphase (bottom
left) cells and a chromosome spread (right) with
LacIGFP (green) bound to multiple copies of lacO
integrated at a single chromosomal locus. DNA is
stained with DAPI (blue). Bar, 10 µm.

use HCT116 cells for this purpose because it is an established
near-diploid colon cancer cell line that faithfully segregates
chromosomes to maintain a stable karyotype (Lengauer et al.,
1997). Cells with integrated lacO and expressing LacIGFP
remained near diploid. The expressed LacIGFP bound to the
chromosomal lacO site, producing a single, bright fluorescent
mark in each interphase nucleus and unique marks on sister
chromatids of mitotic chromosomes (Fig. 1). Accurate segregation of this chromosome during mitosis yielded daughter
cells with single marks in each nucleus, whereas missegregation yielded one daughter cell with no marks and the other with
two (Fig. 2 A).
Using these chromosomally marked cells, we induced
chromosome missegregation through a monastrol washout
strategy (Cimini et al., 1999; Knowlton et al., 2006; Thompson and Compton, 2008) and followed the fate of individual
cell clones. We previously showed that this washout strategy
elevates chromosome missegregation to levels where 33%
of cells missegregate at least one chromosome (Thompson
and Compton, 2008). Mitotic cells were collected and plated
at low density, and subsequent daughter cell pairs were identified using live cell fluorescent microscopy in which the
marked chromosome either missegregated or segregated normally (Fig. 2 B). These cells were readily identifiable despite
the low signal to noise ratio for the chromosomal spot when
viewed under live imaging conditions (Fig. 2 B, arrowheads).
As expected, untreated control cells that properly segregated
the marked chromosome grew into large colonies over a 5-d
period (Fig. 2, B and C). In contrast, cells that missegregated
the marked chromosome failed to divide over the 5-d period
(Fig. 2, B and C). In aggregate, colonies generated from cells
that had undergone the drug washout strategy yet segregated
the marked chromosome correctly showed an intermediate
number of cells compared with colonies derived from untreated control cells and cells that missegregated the marked
chromosome (Fig. 2 C) because they fall into two subsets.
5 out of 15 cell colonies formed one subset that contained
clones with three or fewer cells at the end of the 5 d of imaging.
Colonies in the remaining subset had cell numbers similar to
the untreated controls, indicating that the initial drug washout
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step does not impair subsequent colony growth. Previously,
we showed that HCT116 cells missegregate chromosomes at
a rate of approximately one chromosome in every three cell
divisions using this monastrol washout strategy (Thompson and Compton, 2008). Because one third of the colonies
formed after monastrol washout did not grow beyond two to
three cells, it stands to reason that their growth is delayed in
response to the missegregation of a chromosome different
from the one carrying the fluorescent mark.
Cell cycle delay or arrest under various conditions is often
associated with activation of the tumor suppressor protein p53
(Horn and Vousden, 2007). Using our chromosomally marked
HCT116 cells, we induced chromosome missegregation with
the monastrol washout strategy and then stained for p53 and
one of its downstream targets, the cyclin-dependent kinase inhibitor p21 (Fig. 3). Staining intensities for both p53 and p21
were low in HCT116 cells that segregated the marked chromosome normally but were elevated in cells that missegregated the
marked chromosome. Of note, p53 and p21 staining intensities
were elevated in both daughter cells: one that gained the chromosome and its sibling that lost the chromosome (Fig. 3 A).
In cell populations, 24 h after monastrol washout, elevated
p53 and p21 staining was observed in 30% of HCT116 cells,
which is consistent with the chromosome missegregation rate
induced by this treatment (Fig. 3 B). Intensities for p53 and
p21 were also elevated in 40% of immortalized RPE1 cells
after monastrol washout, showing that similar effects occur
in nontransformed cells (Fig. 3 B). When daughter cell pairs
were directly examined, the specific subset of HCT116 cells
that missegregated the marked chromosome showed that 87%
of nuclei stained positive for p21 and >90% stained positive for
p53, whereas only 40% of the cells that segregated the chromosome properly were positive (Fig. 3 C). The percentage of
p53- and p21-positive cells in general populations (30%) was
skewed downward from the isolated pairs of daughter cells
(40%) because of ongoing cell division of some cells (presumably those with low levels of p21 and p53) during the 24 h
period after monastrol washout in the population experiment.
Similar results were observed using three different HCT116
clones, each derived from independent lacO integrations with

Figure 2. Growth arrest after chromosome missegregation. (A) Schematic for proper segregation and missegregation of a single GFP-marked chromosome.
(B) GFP (left) and phase-contrast images of daughter cells that either segregated the marked chromosome normally (top) or abnormally (bottom) at the indicated times after drug washout. Arrowheads point to the LacIGFP/lacO chromosome mark. (C) Number of cells per clone after no treatment, monastrol washout, and monastrol washout with missegregation (mis-seg) of the marked chromosome. Bars represent mean ± SEM (independent clones counted for control,
n = 49; monastrol, n = 15; and monastrol/mis-seg, n = 22). Bars: (B, left) 10 µm; (B, right) 50 µm.

a different chromosome labeled in each clone. This indicates
that activation of the growth arrest/delay pathway involving the
elevation of p21 and p53 levels is a general response to chromosome missegregation and is not confined to the missegregation of a specific chromosome. The increase in p21 and p53
after drug washout could also be detected by immunoblotting
in both HCT116 and RPE1 cells (Fig. 3 D).

Because the drug washout strategy involves an extended
mitotic arrest, we also induced chromosome missegregation
using an independent strategy whereby we transfected cells with
siRNA specific to the centromere-associated kinesin-13 protein
MCAK (mitotic centromere–associated kinesin; Wordeman
and Mitchison, 1995). Depletion of MCAK increases levels of
merotely (attachment of single kinetochores to microtubules
p53 suppresses aneuploidy • Thompson and Compton

371

Figure 3. p21 and p53 expression after chromosome missegregation. (A) HCT116 cells that have properly segregated (top) or missegregated (bottom)
the marked chromosome 24 h after no treatment (top) or monastrol washout (bottom) were stained for p21, p53, and DAPI and with LacIGFP as indicated.
(B) Percentage of nuclei staining positive for p21 and p53 24 h after control and monastrol washout in populations of HCT116 (left) and RPE1 (right) cells.
Bars represent mean ± SEM of at least three experiments (>300 nuclei counted per condition per experiment). (C) Percentage of nuclei staining positive for
p21 and p53 in chromosomally marked HCT116 cell line after control or monastrol washout in pairs of daughter cells that have either properly segregated
or missegregated (mis-seg) the marked chromosome. Bars represent mean ± SEM of >180 cells in at least three experiments. (D) Immunoblots of untreated
(ctrl) cells or cells after monastrol washout (mon) probed for p21, p53, and tubulin (loading control) in HCT116 and RPE1 cells. Bar, 10 µm.

oriented toward both spindle poles) such that 30–40% of anaphase cells have lagging chromosomes, which promotes chromosome missegregation (Maney et al., 1998; Kline-Smith et al.,
2004). 72 h after transfection of HCT116 cells with MCAKspecific siRNA, MCAK protein levels were reduced to 35% of
control levels (Fig. 4 A), and 33% of anaphase cells had lagging chromosomes, compared with 10% in control untreated
populations. MCAK depletion did not significantly increase the
mitotic index of the cell population (P = 0.7376, 2 test; Fig. 4 B).
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Moreover, live cell imaging showed that MCAK depletion
did not significantly prolong the duration of mitosis (time
from nuclear envelope breakdown [NEB] to anaphase onset)
regardless of whether there were lagging chromosomes or not
(Fig. 4, C and D). Staining intensities for both p53 and p21 were
elevated in MCAK-deficient HCT116 cells that missegregated
the marked chromosome (Fig. 4 E). Again, this was observed
in both daughter cells. In the population of MCAK-deficient
HCT116 cells that correctly segregated the marked chromosome,

p21 and p53 staining intensity was elevated in 30% and
36% of nuclei, respectively, likely caused by missegregation of another chromosome (Fig. 4 F). In the subset of cells
that missegregated the marked chromosome, 80% of nuclei
had elevated p21 staining intensity, and 76% had elevated p53
(Fig. 4 F). As expected, most cells that properly segregated the
marked chromosome after transfection with MCAK-specific
siRNA grew into large colonies over several days (Fig. 4,
G and H). In contrast, cells that missegregated the marked chromosome failed to divide over the same period (Fig. 4, G and H).
As with the monastrol washout experiment, some cells that segregated the marked chromosome properly displayed only three
or fewer cells after 5 d (4 out of 16 colonies). This most likely
reflects a subset of cells that underwent growth arrest induced
by missegregation of an unmarked chromosome (Fig. 4 H).
Many of the remaining colonies that were transfected with
MCAK-specific siRNA grew into colonies with cell numbers
comparable with control cells. However, a subset of these
colonies (58%) contained only 5–10 cells after 5 d of growth.
Growth of cells in this subset of colonies may have been limited
by missegregation of a chromosome after the first division because of the lingering deficiency of MCAK induced by ongoing
RNA interference (Fig. 4 H). These data show that chromosome
missegregation in mitosis stabilizes p53 and the cyclin kinase
inhibitor p21 in the subsequent G1 phase of the cell cycle and
delays cell cycle progression. This is consistent with the observation that rat embryonic fibroblasts undergo a p53-dependent
arrest in G1 after the formation of micronuclei because micronuclei are often the consequence of chromosome missegregation caused by persistent merotelic attachment of microtubules
to kinetochores (Sablina et al., 1998).
To confirm that proliferation defects after chromosome
missegregation are not specific to transformed HCT116 cells,
we induced chromosome missegregation in primary fetal lung
fibroblast IMR-90 cells by depleting MCAK. 72 h after transfection with MCAK-specific siRNA, IMR-90 cells displayed a
sixfold increase in anaphases with lagging chromosomes, which
is indicative of elevated rates of chromosome missegregation.
Because IMR-90 cells are highly motile, we generated cell
clones after transfection with MCAK-specific siRNA by limiting dilution into 96-well plates. We then counted the numbers of
cells in each colony 5 d after plating. Under these conditions,
the number of MCAK-deficient cells that failed to progress into
colonies larger than one cell was significantly higher than that
of control cells (Fig. S1). Although it is impossible to confirm
chromosome missegregation in these primary fibroblasts, these
results are consistent with the growth arrest we observed in
HCT116 cells after chromosome missegregation.
DNA damage is a common mechanism to stabilize p53
(Kastan et al., 1991). Under our experimental conditions, DNA
damage may be induced at centromeric DNA in metaphase or
early anaphase by spindle forces pulling merotelic kinetochores
toward opposite poles. To test for DNA damage, we examined
the levels of phosphorylated histone -H2AX, a modified histone which rapidly appears at sites of double-strand breaks
(Rogakou et al., 1998). Doxorubicin treatment induced DNA
double-strand breaks and generated numerous -H2AX foci on

mitotic chromosomes in anaphase cells (Fig. S2 A). However,
-H2AX foci were not detected on lagging chromosomes that
were induced using the monastrol washout strategy. We also
examined interphase cells after doxorubicin treatment or 24 h
after the monastrol washout (Fig. S2, B and C). As expected,
nuclei in nearly all cells treated with doxorubicin stained positive for -H2AX. In contrast, nuclei from only a small fraction of cells treated with monastrol washout stained positive for
-H2AX, and this fraction is much smaller than the fraction of
cells that would have missegregated a chromosome using this
strategy (Thompson and Compton, 2008) and is not different from control cells. Thus, p53 stabilization in cells that mis
segregate chromosomes is not the result of DNA damage caused
by either the treatments used to induce missegregation or mechanical forces involved in missegregation.
If the stabilization of p53 contributes to the prolonged
cell cycle delay after chromosome missegregation, loss of p53
would permit the growth of aneuploid cells. To test this idea, we
induced chromosome missegregation using a single monastrol
washout in HCT116 cells lacking both alleles of the p53 gene
(Bunz et al., 2002). We then determined the chromosome content of these cells as they propagated without further treatment
using FISH with chromosome-specific probes (Fig. 5). The percentage of untreated p53-null cells that were aneuploid in the
population was low and equivalent to wild-type HCT116 cells.
Immediately after washout of monastrol, there was an equivalent
increase in the percentage of aneuploid cells in both populations.
The percentage of aneuploid cells in HCT116 wild-type populations returned to basal levels by 6 d after treatment (Fig. 5),
as previously shown (Thompson and Compton, 2008), indicating a failure of aneuploid cells to propagate efficiently. In
contrast, the percentage of aneuploid cells in the population of
HCT116 cells lacking p53 remained high 6 d after treatment,
indicating that aneuploid cells in this population propagate and
compete efficiently with diploid cells. This demonstrates that
p53 is a key component of a pathway that provides intolerance
to aneuploidy in somatic cultured human cells.
It has recently been shown that cell cycle arrest is mediated by the p38 stress kinase in response to disruption of the
cytoskeleton (Mikule et al., 2007; Uetake et al., 2007), so we
tested whether the p38-dependent stress pathway participated in
cell cycle delay in cells after chromosome missegregation. We
induced chromosome missegregation in HCT116 cells as well
as in immortalized but nontransformed RPE1 cells by using the
monastrol washout strategy. Using FISH with chromosomespecific probes, we then determined the chromosome content
of the populations as they propagated in the presence of either
the p38 inhibitor SB203580 or the MAPK inhibitor PD98059
(Fig. 6). As expected, the percentage of aneuploid cells in populations of both HCT116 and RPE1 cells increased immediately
after monastrol washout. In the presence of the MAPK inhibitor, the percentage of aneuploid cells in both populations declined to background levels over time (Fig. 6 B). In contrast,
the percentage of aneuploid cells in both populations remained
elevated in the presence of the p38 inhibitor (Fig. 6 A). As p38
is known to directly phosphorylate p53 in response to cellular stress (Bulavin et al., 1999), these data suggest that a stress
p53 suppresses aneuploidy • Thompson and Compton
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Figure 5. p53-null HCT116 cells continue to proliferate after missegregation of chromosomes. p53 wild-type (left) and null (right) cells were treated
with or without (control) monastrol, and mitotic cells were collected by shake-off, plated, and allowed to proliferate with no further treatment. At 4 h,
2 d, and 6 d, cells were harvested, and FISH was performed using probes specific for chromosomes 3, 7, and 15. For each time point/condition,
600 nuclei were counted per chromosome. Bars represent the mean percent deviation from the modal chromosome number, and error bars show SEM.
*, P < 0.05; 2 test.

response can induce a p53-dependent pathway to pause the cell
cycle in response to chromosome missegregation.
Deficiency of p53 alone is not sufficient to generate aneuploidy or CIN in HCT116 cells (Bunz et al., 2002). To test whether
combining p53 deficiency with elevated chromosome missegregation rates generates viable aneuploid and CIN cells, we induced chromosome missegregation for several generations in
p53-deficient HCT116 cells. We quantified modal chromosome
number and the percentage of cells deviating from that mode in
clonal populations of p53 wild-type and null cells after 27 consecutive generations. Both p53 wild-type and null HCT116 cells
maintained a disomic modal copy number with very little deviation from that mode for each chromosome analyzed in this
clonal analysis (Table I). This confirms that these cells are near
diploid and chromosomally stable and that p53 deficiency alone
is insufficient to generate aneuploidy or CIN. Next, we used the
monastrol washout strategy to increase chromosome missegregation rates at each generation during the growth of colonies of
both cell lines. Viable colonies of p53 wild-type cells failed to
grow under these conditions, which is consistent with our previous findings showing that elevating chromosome missegregation rates alone is insufficient to generate viable aneuploid or
CIN cells (Thompson and Compton, 2008). In contrast, elevating chromosome missegregation rates did not inhibit colony
growth from p53-null HCT116 cells. All of these colonies displayed deviation from the modal  chromosome number that
was significantly elevated for each chromosome analyzed in

each individual colony (Table I). Because these percentages
represent aneusomy for specific chromosomes, it is likely
that the overall level of aneuploidy in these colonies was
much higher. These data show that combining elevated chromosome missegregation rates with increased tolerance for a
nondiploid genome through p53 deficiency permits the conversion of otherwise stable diploid cells into cells with the
hallmarks of CIN.
We next tested the long-term genomic stability of cells
derived from these p53-deficient colonies with CIN. We derived subclones from each of the p53-deficient cell colonies
shown in Table I by plating cells at low density. Subclones
were grown for 27 more generations with no additional monastrol washout, and we used FISH to determine the percentage
of cells in each subclone that displayed chromosome numbers
that deviated from the chromosomal mode (Table II). With one
exception (p53/ H subclone 4), all of the subclones displayed
significant deviation from the modal chromosome number
for at least two of the chromosomes analyzed. One subclone
(p53/ J subclone 2) showed exceptionally high deviations
from the mode for all four chromosomes analyzed (Table II)
and had a highly variable karyotype (Fig. S3). Karyotypes of
these subclones often deviated from the normal modal chromosome number of 45, indicating that they were aneuploid
(HCT116 cells are disomic for all autosomes and have lost the
Y chromosome; Fig. S3). Thus, these subclones are aneuploid
in addition to being chromosomally unstable. It is not surprising

Figure 4. p21 and p53 expression and growth arrest after chromosome missegregation induced by MCAK depletion. (A) Western blot of HCT116 cells
72 h after transfection with MCAK siRNA (+) or no siRNA () probing for MCAK and tubulin (loading control). (B) Mitotic indexes of HCT116 cells 72 h
after MCAK or mock knockdown (kd). Bars represent mean ± SEM (three experiments; >500 cells in each experiment). (C) Still frames of control (top) or
MCAK knockdown (bottom) in HCT116 cells expressing GFP-H2B, with time given in minutes after NEB. A lagging chromosome in MCAK knockdown
anaphase is labeled with an arrowhead. (D) Timing (in minutes) from NEB to anaphase onset in HCT116 cells after control or MCAK knockdown. Bars
represent mean ± SEM. (E) HCT116 cells that have properly segregated (top) or missegregated (bottom) the marked chromosome in control (top) or MCAKdeficient cells (bottom) stained for p21, p53, and DAPI and with LacIGFP as indicated. (F) Percentage of nuclei positive for p21 and p53 after normal
or missegregation (mis-seg) of the marked chromosome in control or MCAK-depleted HCT116 cells. Bars represent mean ± SEM of >150 cells in at least
three experiments. (G) GFP (left) and phase-contrast images of daughter cells that segregated the marked chromosome normally (top) or abnormally in
MCAK-deficient cells (bottom) at the indicated times after mitotic shake-off. Arrowheads point to the LacIGFP/lacO chromosome mark. (H) Number of cells
in each clone after control or MCAK knockdown or MCAK knockdown cells that have missegregated the marked chromosome. Bars represent mean ± SEM
(independent clones counted for control, n = 7; MCAK, n = 16; and MCAK/mis-seg, n = 14). Bars: (C) 5 µm; (E and G [left]) 10 µm; (G, right) 60 µm.

p53 suppresses aneuploidy • Thompson and Compton
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Figure 6. Inhibition of p38 stress kinase but not MAPK allows proliferation of aneuploid cells. (A and B) HCT116 cells with wild-type p53 and RPE1 cells
were treated as described in Fig. 5. After shake-off, cells were grown in the presence of p38 inhibitor (SB203580; A) or MAPK inhibitor (PD98059; B)
for the remainder of the experiment. For each time point/condition, 600 nuclei were counted per chromosome. Bars represent the mean percent deviation
from the modal chromosome number, and error bars show SEM. *, P < 0.05; 2 test.

that most subclones had karyotypes with modes near 45 despite
being CIN because there is no selective pressure for specific
chromosome combinations under in vitro culture conditions,
as would be expected for a tumor that is growing in situ. In
the absence of selective pressure, CIN induces significant deviation from modal chromosome numbers and broadens the
distribution of karyotypes in the population (Fig. S3) without

shifting the modal chromosome number of the population far
from 45. Moreover, the inherent chromosome missegregation
rate in these subclones is unlikely to reach the extremely high
missegregation rate induced by monastrol washout (Thompson
and Compton, 2008), explaining why these subclones have
lower percentages of cells with chromosome numbers that deviate from the mode compared with the initial clones despite

Table I. Modal chromosome number and percentage of cells that deviate from modal chromosome number in p53 wild-type and null clones
Cell line

Mode (percent deviation)
Chr 2

+/+

p53 control (clone A)
p53+/+ control (clone B)
p53+/+ control (clone C)
p53/ control (clone D)
p53/ control (clone E)
p53/ control (clone F)
p53/ monastrol 27 d (clone
p53/ monastrol 27 d (clone
p53/ monastrol 27 d (clone
p53/ monastrol 27 d (clone

G)
H)
I)
J)

Chr, chromosome. 300 nuclei were counted per chromosome per clone.
a

Clone used for statistical analysis.

b

Deviation from mode is statistically significant (P < 0.05, 2 test).
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2
2
2
2
2
2
2
2
2
2

Chr 4
a

(3.0)
(2.7)
(3.0)
(3.3)
(3.3)
(2.0)
(18.0)b
(8.0)b
(17.3)b
(13.3)b

2
2
2
2
2
2
2
2
2
2

a

(2.7)
(2.7)
(2.0)
(3.0)
(3.3)
(2.7)
(26.0)b
(18.7)b
(24.3)b
(33.7)b

Chr 7

Chr 15

2
2
2
2
2
2
2
2
2
2

2
2
2
2
2
2
2
2
2
2

(2.7)
(4.0)a
(2.7)
(2.3)
(2.7)
(2.0)
(10.0)b
(18.7)b
(20.0)b
(20.3)b

(3.7)a
(3.7)
(3.7)
(3.7)
(4.3)
(3.7)
(21.0)b
(23.0)b
(29.7)b
(23.7)b

Table II. Modal chromosome number and percentage of nonmodal cells in subclones generated from p53-null clones induced to persistently
missegregate chromosomes for 27 generations
Cell line

Mode (percent deviation)
Chr 2

p53
p53/
p53/
p53/
p53/
p53/
p53/
p53/
/

G subclone 1
H subclone 1
H subclone 2
H subclone 3
H subclone 4
I subclone 1
J subclone 1
J subclone 2

2
2
2
2
2
2
2
4

Chr 4
a

(3.3)
(3.3)
(14.3)a
(10.3)a
(5.0)
(8.7)a
(4.7)
(55.3)a

2
2
2
2
2
2
2
2

(5.3)
(11.3)a
(16.7)a
(11.0)a
(4.7)
(16.7)a
(7.0)
(67.3)a

Chr 7
2
2
2
2
2
2
2
4

Chr 15
a

(8.3)
(9.0)a
(18.0)a
(14.0)a
(4.7)
(11.7)a
(9.7)a
(62.0)a

2
2
2
2
2
2
2
2

(13.3)a
(9.0)a
(14.7)a
(13.0)a
(6.3)
(12.3)a
(8.3)a
(51.0)a

Chr, chromosome. 300 nuclei were counted per chromosome per subclone.
a

Deviation from mode is statistically significant compared with p53+/+ controls in Table I (P < 0.05, 2 test).

similar generation times. These data show that the acquisition
of tolerance for aneuploidy through p53 deficiency coupled
with initial chromosome missegregation renders cells in these
subclones genetically unstable and intrinsically CIN.
To discount the possibility that the p53/ HCT116 cells
have acquired an adaptation that permits their tolerance for nondiploid genomes, we transfected our chromosomally marked
HCT116 (p53+/+) cells with p53-specific siRNA (Fig. S4). We
induced chromosome missegregation by simultaneously transfecting cells with MCAK-specific siRNA. Immunoblotting confirmed deficiency of p53 after siRNA transfection (Fig. S4 A),
and an increase in lagging chromosomes at anaphase confirmed
depletion of MCAK under these conditions (Fig. S4 B). As expected, cells that were deficient in p53 alone and that properly
segregated the marked chromosome grew into large colonies
over a 5-d period (Fig. S4 C). p53-deficient cells that missegregated the marked chromosome because of MCAK deficiency
also grew into large colonies over a 5-d period (Fig. S4 C).
Thus, acute loss of p53 function from otherwise wild-type cells
generates tolerance for the propagation of aneuploid cells and
confirms our data generated using a cell line that has been engineered to be deficient in p53.

Discussion
In summary, we show that the p53-dependent pathway is a
mechanism to limit the growth of diploid human cells in culture after chromosome missegregation. Our data fit a pathway
whereby chromosome missegregation generates a p38 kinase–
dependent stress response that activates p53 to induce the cyclin
kinase inhibitor p21, which delays cell cycle progression. The
cellular stress that activates this pathway is most likely derived
from the imbalance of products encoded by genes on the aneu
somic chromosome. Trisomy has been shown to create gene
dosage imbalances in both budding yeast and mammals (Torres
et al., 2007; Williams et al., 2008), and, by logical extension,
monosomy would also generate gene dosage imbalances. This
provides a likely explanation for why our data show activation
of the p53-dependent pathway in both the trisomic and the monosomic daughter cells after chromosome missegregation. The
p53 pathway has been shown to promote CIN when associated

with a compromised spindle assembly checkpoint (Burds
et al., 2005). Our data show that the p53 pathway potently
inhibits cell growth after missegregation of single chromosomes.
The importance for this pathway to respond to imbalances in
single chromosomes to prevent accumulation of aneuploid cells
is readily apparent given that the human body contains millions
of dividing cells at any given time (Alberts et al., 2002) and
that a chromosome will spontaneously missegregate about once
every 100 cell divisions (Cimini et al., 1999; Thompson and
Compton, 2008).
The prolonged cell cycle delay that is imparted by the
p53 pathway in response to chromosome missegregation represents one of several different cellular responses to aneuploidy. For example, in some contexts, trisomy merely slows
cellular growth rates (Williams et al., 2008), and budding yeast
lack a p53 gene, so the responses reported in aneuploid yeast
(Torres et al., 2007) cannot involve a p53-dependent pathway.
In addition, there is a growing body of literature showing that
aneuploidy is common in human and mouse neural progenitor cells and neurons, and these probably retain a functional
p53 pathway (Rehen et al., 2001, 2005; Kaushal et al., 2003;
Yang et al., 2003; Kingsbury et al., 2005). For example, 33%
of mouse neuroblasts are aneuploid compared with only 3.4%
of adult lymphocytes (Rehen et al., 2001), and high levels of
aneuploidy have also been seen in human brain cells (Rehen
et al., 2005), indicating that those cell types tolerate an aneuploid state. Moreover, it has been reported that deletion of p53
in embryonic neural progenitor cells actually decreases the percentage of aneuploid cells, suggesting that p53-mediated arrest
in response to aneuploidy is not the sole mechanism to inhibit
aneuploid proliferation (McConnell et al., 2004). Also, levels of
aneuploidy (often of sex chromosomes) in leukocytes increase
as people age (Jacobs, et al., 1963), and there is no reported
link to loss of p53 in these cases. Finally, aneuploidy increases
in many tissues of mice that are heterozygous for mutations
in genes encoding checkpoint proteins, and it is unlikely that
these have all lost p53 function (Michel et al., 2001; Babu et al.,
2003; Baker et al., 2004; Iwanaga et al., 2007; Jeganathan
et al., 2007; Weaver et al., 2007). Interestingly, Vanneste et al.
(2009) recently showed that human cleavage-stage embryos
show a high level of aneuploidy, with 19 out of 23 embryos
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containing blastomeres with whole chromosome losses or
gains. Embryonic stem cells have reduced levels of some checkpoint proteins and a shortened G1 phase, suggesting that the
developing embryo may relax checkpoint control and sacrifice
chromosome segregation accuracy to expedite proliferation
(Egozi et al., 2007; Ambartsumyan and Clark, 2008). These
embryologic adaptations to aneuploidy may underlie the viability of trisomic mouse cells (Williams et al., 2008) and humans
(i.e., Down’s syndrome). In addition, mosaic embryos containing both aneuploid and diploid cells can result in chromosomally
normal fetuses (Vanneste et al., 2009). This selective retention
of diploid cells may explain why mice heterozygous for mutations in mitotic checkpoint genes are viable and have no obvious developmental defects (for review see Foijer et al., 2008).
Collectively, these findings indicate that the cellular response
to aneuploidy varies according to the specific cell context (i.e.,
tissue type, embryonic vs. somatic cell, etc.), and responses
may vary depending on which chromosome has missegregated.
Activation of the p53 pathway observed in this study appears to
be critical to maintain the diploid karyotype of the population of
cells grown under culture conditions. This may be the preferred
response of somatic cells to prevent aneuploidy from contributing to the initiation or promotion of cancer that frequently arises
in epithelial cell types. However, cells in other tissue contexts
in humans and mice do not appear to respond to aneuploidy by
activation of the p53 pathway.
p53 is one of the most highly mutated genes in cancer,
and there is a strong correlation between aneuploid tumors
and mutation of p53 (Campomenosi et al., 1998), supporting
the idea that loss of p53 permits aneuploid cell propagation.
For example, in some tumors and precancerous conditions
including Barrett’s esophagus, p53 mutations arise in diploid
cells before aneuploidy (Blount et al., 1994). Furthermore,
diploid cells in culture often inactivate p53 and become aneu
ploid at the same time during the immortalization process
(Harvey et al., 1993), and cells from nonmalignant tissues in
p53-null mice are often aneuploid (Fukasawa et al., 1997).
However, it remains controversial whether mutation of p53
is obligatory for aneuploid cell propagation. For example,
aneuploid embryonic cells divide for multiple generations
before embryonic lethality (Dobles et al., 2000; Kalitsis et al.,
2000; Williams et al., 2008) in contrast to the growth inhibition we observe in cultured somatic cells. Moreover, p53
is not lost or mutated in many aneuploid tumor cell lines
(www.sanger.ac.uk/perl/genetics/CGP/cosmic), and in some
cancers, aneuploidy appears during tumorigenesis before
p53 mutation (Baker et al., 1990). These tumors may harbor
mutations in genes participating in other pathways that limit
aneuploid cell growth or they may have impaired signaling
upstream or downstream of p53. For example, the stress
kinase pathway is inactivated in some tumors (Greenman
et al., 2007; Ventura et al., 2007) and attenuated in transformed cells (Mikhailov et al., 2007), which would limit the
capacity of aneuploidy-induced gene dosage imbalances to
activate the p53 pathway. Alternatively, some tumor cells
are wild type for p53 but have mutations in the downstream
cyclin kinase inhibitor genes, limiting the functionality of
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the p53 pathway (e.g., MCF7 breast carcinoma cells; Berns
et al., 1995), or have inactivated regulators upstream of p53
(e.g., p14ARF expression is often lost by deletion or promoter
hypermethylation in many tumors, and this loss occurs at
early stages of tumorigenesis in some tumors; Esteller et al.,
2000; Vousden and Lu, 2002) or overexpress p53 inhibitors
such as MDM2 or -4 (Toledo and Wahl, 2006).
The chromosome missegregation rate in human cancer
cells with CIN is alarmingly high. CIN cells missegregate a
chromosome every one to five divisions depending on the cell
line (Thompson and Compton, 2008). These high missegregation rates are matched by treatments that elevate merotely
(Thompson and Compton, 2008) and are likely to be matched
by securin depletion (Pfleghaar et al., 2005). The cell cycle
delay imposed by repeated activation of the p53 pathway in response to such frequent chromosome missegregation explains
why otherwise diploid cells fail to survive when missegregation rates are elevated to levels equivalent to those of CIN
cancer cells (Pfleghaar et al., 2005; Thompson and Compton,
2008). This view may explain the reported increases in the
percentage of aneuploid cells in populations of HCT116 cells
that are heterozygous for mutations in the Mad2 gene (Michel
et al., 2001). Chromosome missegregation rates were not directly measured in Mad2+/ cells and may be lower than those
of cells without securin or with elevated merotely because the
percentage of aneuploid cells in populations of Mad2+/ cells
after 25 generations is similar to that observed in cells without
securin or with elevated merotely after just 2 to 5 generations
(Pfleghaar et al., 2005; Thompson and Compton, 2008). Thus,
loss of p53 function can provide tolerance necessary for cellular survival of otherwise diploid cells when chromosome
missegregation rates reach those observed in human cancer
cells with CIN.
Finally, our data fit a model whereby abnormal numbers
of chromosomes disrupt the sensitive balance of mitotic proteins, which in turn undermines faithful chromosome segregation to produce further aneuploidy (Duesberg et al., 1998,
1999). If the dosage of any one of the many proteins involved
in ensuring chromosome segregation fidelity is disrupted by the
missegregation of the chromosome carrying that gene, the resulting imbalance could further compromise chromosome segregation accuracy. In this context, we demonstrate that by
combining persistent chromosome missegregation with loss of
the p53 pathway, we can convert stable diploid cells into aneuploid cells that have karyotypes reminiscent of many human
tumors. Moreover, we show that otherwise diploid cells become intrinsically CIN once aneuploidy is induced in a genetic
background that tolerates chromosome changes. Although
these results fit some aspects of the model proposed by Duesberg
et al. (1998, 1999), there is divergence in other aspects because
we show that aneuploidy and CIN only become self-propagating in a genetic background in which the p53 pathway has been
inactivated. Thus, conversion of diploid progenitor cells into
cells that are aneuploid and CIN takes two steps; reduction in
chromosome segregation fidelity and acquisition of tolerance
for a nondiploid genome that can arise through inactivation
of the p53 pathway.

Materials and methods
Cell culture
Cells were maintained at 37°C with 5% CO2 in Dulbecco’s modified medium (RPE1 and IMR-90) or McCoy’s 5a (HCT116) supplemented with
10% FBS, 50 IU/ml penicillin, and 50 µg/ml streptomycin. Paired isogenic
HCT116 cell lines with wild-type p53 or null p53 were a gift from B. Vogelstein (Johns Hopkins Oncology Center, Baltimore, MD). IMR-90 cells were
purchased from the American Type Culture Collection and used between
passage 3 and 7 (after we obtained them) for all experiments.
Plasmid transfections
HCT116 cells were transfected with p3-SS-GFP-lacI-NLS (LacIGFP plasmid;
provided by W. Bickmore, Western General Hospital, Edinburgh, Scotland, UK; Chubb et al., 2002) using Lipofectamine 2000 (Invitrogen) and
placed under hygromycin selection at 300 µg/ml for 20 d. Clones expressing LacIGFP were then transfected simultaneously with pJRC49 (plasmid with multiple lacO sites) and JCR41 (blasticidin resistance cassette;
plasmids provided by W. Bickmore; Chubb et al., 2002) and placed under
blasticidin selection at 2 µg/ml. Clones were isolated after 15–20 d and
screened for LacIGFP expression and integration of lacO in a single locus,
and selection was maintained by alternating blasticidin and hygromycin
selection every 5–7 d. Three independent clones with the brightest chromosomal marks were examined for p21 and p53 expression in cells that
missegregated the labeled chromosome after monastrol washouts and
MCAK knockdown (see next section). Chromosome spreads were performed to verify that the labeled chromosome differed in each of the clones.
One clone was chosen for live cell imaging (Fig. 2) because it had the
highest signal to noise ratio.
RNA interference
MCAK was depleted using a published sequence (Cassimeris and Morabito,
2004; Applied Biosystems). p53 was depleted using the predesigned sequence 5-GGGAGUUGUCAAGUCUUGC-3 from Applied Biosystems.
200 nM double-stranded RNA was transfected into cells using Oligofectamine as previously described (Ganem and Compton, 2004). Cells
were analyzed or used for subsequent experiments 60–72 h later.
GFP and phase-contrast live cell imaging over extended time period
For monastrol washouts, cells were treated with 100 µM monastrol or remained untreated (control) for 8 h. Mitotic cells were isolated by shake-off,
washed with PBS, and plated at low density in 6-well plates. For MCAK
knockdowns, cells were harvested 72 h after transfection as described in
the previous section and plated at low density in 6-well plates. For both
monastrol and MCAK experiments, 16 h after plating, pairs of daughter cells were screened for segregation of the marked chromosome by
fluorescence microscopy, and a single focal plane GFP and phase image
were acquired using a Plan Fluor 40× NA 0.6 ELW air objective on a
microscope (TE 2000-E; Nikon) at 37°C equipped with a cooled chargecoupled device camera (Orca ER; Hamamatsu Photonics). The spatial
position of each pair of daughter cells was recorded using Phylum Live
software (PerkinElmer), and phase-contrast images were acquired for each
position at 24-h intervals for a total of 5 d. Cell clones were included in
histograms only if they could be distinguished as two separate daughter
cells to exclude cells that may have failed cytokinesis. Autocontrast was
applied to images using Photoshop CS2 (Adobe).
IMR-90 cells were transfected with MCAK siRNA as described in the
previous section. 72 h after transfection, cells were split into 96-well plates
at a concentration of one cell per every two wells. Cells were incubated for
an additional 5 d, and the number of cells per well was counted.
Fixed cell imaging
Cells were fixed in 3.5% PFA and stained, and images were acquired
as previously described (Thompson and Compton, 2008). For monastrol
washouts, cells were grown in flasks, treated with 100 µM monastrol for
8 h, isolated by mitotic shake-off, washed with PBS, plated on coverslips,
and incubated for 24 h. For MCAK knockdowns, cells were grown and
transfected on coverslips and fixed at 72 h after siRNA transfection. 1 µM
doxorubicin was added to cells 4 h before fixation (interphase) or at 0.5 µM
50 min before fixation for mitotic cells. Antibodies were specific for p21
(1:500; Santa Cruz Biotechnology, Inc.), p53 (1:1,000; Santa Cruz
Biotechnology, Inc.), anticentromere antibody (1:1,000; provided by
K. Sullivan, National University of Ireland, Galway, Ireland), and/or
-H2AX (1:1,000; Novus Biologicals) and were detected with FITC,
Texas red, and/or Cy5. Images were acquired on the aforementioned

microscope with a Plan-Apochromat 60× NA 1.4 oil immersion objective. 0.25-µm optical sections in the z axis were collected. Iterative
restoration was performed using Phylum Live software. Autocontrast using
Photoshop CS2 was applied to images. Nuclei were scored positive
for p21 and p53 accumulation if pixel intensities inside the nucleus
were at least 1.5 times and 2.0 times, respectively, higher than pixel
intensities in untreated cells. Cells were scored positive for -H2AX foci
when pixel intensities of foci matched or were brighter than single foci
in doxorubicin-treated cells.
Live cell imaging of HCT116 GFP-H2B
Live imaging of HCT116 cells expressing GFP-H2B was performed as previously described (Thompson and Compton, 2008). HCT116 cells expressing H2BGFP growing on coverslips were transfected with MCAK siRNA as
described in RNA interference. At 48–72 h, coverslips were mounted on
modified rose chambers, and mitotic cells were imaged at 37°C with the
60× objective on the aforementioned microscope by acquiring 27 0.5-µm
optical sections in the z axis in the GFP channel at 1-min intervals. Images
were deconvolved using Phylum Live, autocontrast was applied to images
using Photoshop CS2, and still frames represent full volume projections.
Time from NEB to anaphase was calculated by averaging movies from
multiple MCAK knockdowns.
Immunoblotting
Total cell protein was separated by SDS-PAGE and transferred to a polyvinylidene fluoride membrane. Membranes were incubated with antibodies
for p53 (1:2,500), p21 (1:500), MCAK (1:1,000), or tubulin (1:5,000;
DM1-; Sigma-Aldrich) in 1% milk in Tris-buffered saline and detected with
HRP-conjugated secondary antibodies followed by chemiluminescence.
Band intensities were quantified using ImageJ software (National Institutes
of Health).
Monastrol washout time courses and CIN assay
Colony growth and FISH analyses were performed as previously described
(Thompson and Compton, 2008). For clonal analyses, HCT116 p53+/+ and
p53/ cells were grown in flasks. Once cells reached 70–80% confluency, they were treated with 100 µM monastrol or untreated for 8 h. Mitotics
were isolated by shake-off, washed with PBS, and plated at very low density
in 100-mm plates in fresh medium with no drug. Cells were allowed to
recover and finish dividing for 16 h and then treated with either monastrol
or fresh media (control) for 8 h followed by two washes with PBS and once
again incubated in fresh medium with no drug for 16 h. p53+/+ and p53/
control cells and p53/ monastrol washout cells were treated in this manner
for a total of 27 generations. At 15–20 generations, clones were harvested by trypsinization of colonies using cloning rings. At 27 generations,
cells were harvested for FISH. For subclones derived from p53/ monastrol
27 d clones, at generation 27, a small percentage of the cells were plated
at very low density, and subclones were grown for an additional 27 generations. Chromosome spreads were prepared from mitotic cells from populations of untreated p53+/+ and p53/ HCT116 cells and p53/ subclones
grown for >50 generations treated with 150 ng/ml nocodazole for 16 h.
Cells were collected by trypsinization, briefly resuspended in 75 mM potassium chloride, fixed, washed twice in 3:1 methanol/acetic acid mix,
dropped onto wet slides, air dried, and stained with DAPI.
For analysis of aneuploidy in the populations, HCT116 and RPE1
cells were grown in flasks and treated with monastrol or fresh medium as
described in the previous paragraph. Mitotic cells were isolated by shakeoff, washed with PBS, and replated in 100-mm dishes. Cells were grown
in fresh medium with no further treatment, and at 4 h, 2 d, and 6 d
(HCT116) or 8 d (RPE1), cells were harvested for FISH analysis. For kinase
inhibitor experiments, medium containing 10 µM SB203580 or 50 µM
PD98059 was added to the cells immediately after washout of monastrol,
and cells were maintained in the presence of the drug for the remainder of
the experiment.
Online supplemental material
Fig. S1 shows the percentage of IMR-90 cells that did not form a colony in
MCAK knockdown and control cells. Fig. S2 displays -H2AX staining in
RPE1 cells after monastrol washout or treatment with doxorubicin. Fig. S3
displays histograms of karyotypes from untreated p53+/+ and p53/ cells
and p53/ subclones derived from clones treated for 27 d with monastrol
washout and representative images of karyotypes. Fig. S4 shows the fate
of cell clones that have missegregated chromosomes in cells depleted of
both MCAK and p53. Online supplemental material is available at http://
www.jcb.org/cgi/content/full/jcb.200905057/DC1.
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